ArticleBMC cancer2026

Effectiveness and safety of PD-1/PD-L1 inhibitors plus lenvatinib with or without Gemox chemotherapy in advanced intrahepatic cholangiocarcinoma.

Shuofeng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.